Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

Edited by Todd R. Klaenhammer, North Carolina State University, Raleigh, NC, and approved August 13, 2010 (received for review January 29, 2010)
September 7, 2010
108 (supplement_1) 4562-4569

Abstract

Probiotic bacteria, specific representatives of bacterial species that are a common part of the human microbiota, are proposed to deliver health benefits to the consumer by modulation of intestinal function through largely unknown molecular mechanisms. To explore in vivo mucosal responses of healthy adults to probiotics, we obtained transcriptomes in an intervention study after a double-blind placebo-controlled cross-over design. In the mucosa of the proximal small intestine of healthy volunteers, probiotic strains from the species Lactobacillus acidophilus, L. casei, and L. rhamnosus each induced differential gene-regulatory networks and pathways in the human mucosa. Comprehensive analyses revealed that these transcriptional networks regulate major basal mucosal processes and uncovered remarkable similarity to response profiles obtained for specific bioactive molecules and drugs. This study elucidates how intestinal mucosa of healthy humans perceives different probiotics and provides avenues for rationally designed tests of clinical applications.

Continue Reading

Data Availability

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE18741).

Acknowledgments

We thank J. Jansen and M. Grootte Bromhaar (Wageningen University) for excellent microarray hybridizations, Roger Bongers and Bert van de Bunt for preparing the freeze-dried bacterial preparations used during the interventions, Iris van Swam for excellent technical support in QPCR analyses (NIZO Food Research), and Willem M. de Vos (Wageningen University) for his unrelenting support for this work and the many constructive discussions. P.v.B. was supported by the BioRange program of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. The work of G.H. and M.B. is supported by the “Besluit Subsidies Investeringen Kennisinfrastructuur” (BSIK) program Netherlands Genomics Initiative and the Innovative Research Program Genomics.

Supporting Information

Appendix (PDF)
Supporting Information

References

1
W Jia, H Li, L Zhao, JK Nicholson, Gut microbiota: A potential new territory for drug targeting. Nat Rev Drug Discov 7, 123–129 (2008).
2
MH Tschöp, P Hugenholtz, CL Karp, Getting to the core of the gut microbiome. Nat Biotechnol 27, 344–346 (2009).
3
AJ Macpherson, NL Harris, Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4, 478–485 (2004).
4
II Ivanov, et al., Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337–349 (2008).
5
A van Belkum, EE Nieuwenhuis, Life in commercial probiotics. FEMS Immunol Med Microbiol 50, 281–283 (2007).
6
S Salminen, E Isolauri, Intestinal colonization, microbiota and probiotics. J Pediatr 149, S115–S120 (2006).
7
M Weng, MA Walker, Bacterial colonization, probiotics and clinical disease. J Pediatr 149, S107–S114 (2006).
8
DA Peterson, DN Frank, NR Pace, JI Gordon, Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3, 417–427 (2008).
9
AL D'Souza, C Rajkumar, J Cooke, CJ Bulpitt, Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ 324, 1361 (2002).
10
M Kalliomäki, E Isolauri, Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 3, 15–20 (2003).
11
S Sazawal, et al., Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6, 374–382 (2006).
12
H Szajewska, M Ruszczyński, A Radzikowski, Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J Pediatr 149, 367–372 (2006).
13
BC Johnston, AL Supina, M Ospina, S Vohra, Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 18, CD004827 (2007).
14
J Lee, D Seto, L Bielory, Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 121, 116–121 (2008).
15
M Kalliomäki, S Salminen, T Poussa, H Arvilommi, E Isolauri, Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869–1871 (2003).
16
M Beausoleil, et al., Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 21, 732–736 (2007).
17
RB Canani, et al., Probiotics for treatment of acute diarrhoea in children: Randomised clinical trial of five different preparations. BMJ 335, 340 (2007).
18
J Hol, et al., The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial. J Allergy Clin Immunol 121, 1448–1454 (2008).
19
NM de Roos, MB Katan, Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998. Am J Clin Nutr 71, 405–411 (2000).
20
M Saxelin, S Tynkkynen, T Mattila-Sandholm, WM de Vos, Probiotic and other functional microbes: From markets to mechanisms. Curr Opin Biotechnol 16, 204–211 (2005).
21
P van Baarlen, et al., Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA 106, 2371–2376 (2009).
22
P van Baarlen, HP van Esse, RJ Siezen, BP Thomma, Challenges in plant cellular pathway reconstruction based on gene expression profiling. Trends Plant Sci 13, 44–50 (2008).
23
H Li, et al., Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97, 773–778 (2000).
24
S Matsukura, et al., Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin Exp Allergy 36, 1049–1062 (2006).
25
C Wietek, LA O'Neill, Diversity and regulation in the NF-κB system. Trends Biochem Sci 32, 311–319 (2007).
26
E Gonzalez-Rey, A Chorny, M Delgado, Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 7, 52–63 (2007).
27
JH Cho, The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8, 458–466 (2008).
28
P Schneider, J Tschopp, BAFF and the regulation of B cell survival. Immunol Lett 88, 57–62 (2003).
29
J Lamb, et al., The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929–1935 (2006).
30
J Lamb, The Connectivity Map: A new tool for biomedical research. Nat Rev Cancer 7, 54–60 (2007).
31
SE Aeder, PM Martin, JW Soh, IM Hussaini, PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 23, 9062–9069 (2004).
32
RM Uht, S Amos, PM Martin, AE Riggan, IM Hussaini, The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway. Oncogene 26, 2885–2893 (2007).
33
CW Van Niel, C Feudtner, MM Garrison, DA Christakis, Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics 109, 678–684 (2002).
34
CO Elson, et al., Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132, 2359–2370 (2007).
35
G Paturi, M Phillips, KS Kailasapathy, Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J Food Prot 71, 796–801 (2008).
36
L Yang, et al., IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454, 350–352 (2008).
37
T Ranson, et al., IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101, 4887–4893 (2003).
38
J Brady, Y Hayakawa, MJ Smyth, SL Nutt, IL-21 induces the functional maturation of murine NK cells. J Immunol 172, 2048–2058 (2004).
39
N Satoh-Takayama, et al., Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958–970 (2008).
40
CM Galdeano, G Perdigón, The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13, 219–226 (2006).
41
MT Tien, et al., Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 1228–1237 (2006).
42
M Kalliomäki, et al., Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357, 1076–1079 (2001).
43
M Schultz, et al., Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 70, 165–173 (2003).
44
SK Yang, L Eckmann, A Panja, MF Kagnoff, Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113, 1214–1223 (1997).
45
BD Korman, DL Kastner, PK Gregersen, EF Remmers, STAT4: Genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8, 398–403 (2008).
46
L Steinman, A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13, 139–145 (2007).
47
S Di Caro, et al., Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 37, 320–329 (2005).
48
Y Tao, et al., Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290, C1018–C1030 (2006).
49
F Yan, DB Polk, Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959–50965 (2002).
50
F Yan, et al., Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562–575 (2007).
51
M Müller, S Kersten, Nutrigenomics: Goals and strategies. Nat Rev Genet 4, 315–322 (2003).
52
L Afman, M Müller, Nutrigenomics: From molecular nutrition to prevention of disease. J Am Diet Assoc 106, 569–576 (2006).

Information & Authors

Information

Published in

Go to Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences
Vol. 108 | No. supplement_1
March 15, 2011
PubMed: 20823239

Classifications

Data Availability

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE18741).

Submission history

Published online: September 7, 2010
Published in issue: March 15, 2011

Keywords

  1. gene regulation
  2. host–microbe interactions
  3. lactobacillus
  4. transcriptomics
  5. gut bacteria

Acknowledgments

We thank J. Jansen and M. Grootte Bromhaar (Wageningen University) for excellent microarray hybridizations, Roger Bongers and Bert van de Bunt for preparing the freeze-dried bacterial preparations used during the interventions, Iris van Swam for excellent technical support in QPCR analyses (NIZO Food Research), and Willem M. de Vos (Wageningen University) for his unrelenting support for this work and the many constructive discussions. P.v.B. was supported by the BioRange program of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. The work of G.H. and M.B. is supported by the “Besluit Subsidies Investeringen Kennisinfrastructuur” (BSIK) program Netherlands Genomics Initiative and the Innovative Research Program Genomics.

Notes

This paper results from the Arthur M. Sackler Colloquium of the National Academy of Sciences, “Microbes and Health,” held November 2–3, 2009, at the Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering in Irvine, CA. The complete program and audio files of most presentations are available on the NAS Web site at http://www.nasonline.org/SACKLER_Microbes_and_Health.
This article is a PNAS Direct Submission.

Authors

Affiliations

Peter van Baarlen2
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
Centre for Molecular and Biomolecular Informatics, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands;
Present address: Host–Microbe Interactomics Group, Wageningen University, P.O. Box 338, 6700 AH, Wageningen, The Netherlands.
Freddy Troost2
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
Department of Internal Medicine, Division of Gastroenterology-Hepatology, Maastricht University, 6200 MD Maastricht, The Netherlands;
Cindy van der Meer
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
NIZO Food Research, 6710 BA Ede, The Netherlands;
Guido Hooiveld
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
Nutrition, Metabolism, and Genomics Group, Division of Human Nutrition, Wageningen University, 6700 EV Wageningen, The Netherlands; and
Mark Boekschoten
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
Nutrition, Metabolism, and Genomics Group, Division of Human Nutrition, Wageningen University, 6700 EV Wageningen, The Netherlands; and
Robert J. M. Brummer
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
Department of Internal Medicine, Division of Gastroenterology-Hepatology, Maastricht University, 6200 MD Maastricht, The Netherlands;
Present address: School of Health and Medical Sciences, Örebro University, 701 82 Örebro, Sweden.
Michiel Kleerebezem4 [email protected]
Top Institute Food and Nutrition, 6700 AN Wageningen, The Netherlands;
NIZO Food Research, 6710 BA Ede, The Netherlands;
Laboratory of Microbiology, Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands

Notes

4
To whom correspondence should be addressed. E-mail: [email protected].
Author contributions: F.T., R.J.M.B., and M.K. designed research; P.v.B., F.T., C.v.d.M., R.J.M.B., and M.K. performed research; P.v.B., G.H., M.B., and M.K. analyzed data; and P.v.B., G.H., and M.K. wrote the paper.
2
P.v.B. and F.T. contributed equally to this work.

Competing Interests

The authors declare no conflict of interest.

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Citation statements

Altmetrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Get Access

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways
    Proceedings of the National Academy of Sciences
    • Vol. 108
    • No. supplement_1
    • pp. 4513-4695

    Media

    Figures

    Tables

    Other

    Share

    Share

    Share article link

    Share on social media